Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.15 USD | 0.00% | +1.77% | +13.86% |
05-15 | Canaccord Genuity Trims Price Target on Passage Bio to $13 From $14, Maintains Buy Rating | MT |
05-14 | Passage Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.86% | 70.89M | |
+10.84% | 114B | |
+10.69% | 105B | |
-4.83% | 23.83B | |
-0.82% | 21.73B | |
-10.12% | 18.1B | |
-42.12% | 16.34B | |
-17.51% | 16.13B | |
+2.12% | 13.75B | |
+32.64% | 11.76B |
- Stock Market
- Equities
- PASG Stock
- News Passage Bio, Inc.
- Passage Bio Appoints William Chou as CEO